Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
3D Global Biotech
New Taipei, Taiwan3dglobalbiotech.com.tw ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
3D Global Biotech has developed and commercially launched several Class III medical devices and bio-ink products for hard and soft tissue reconstruction, collaborating with leading medical and academic institutions; key products include bone filling materials, craniofacial implants, and hydrogel bio-inks. The company generated significant sales in Taiwan, with its revenue showing substantial growth into 2024[4].
- Therapeutic areas
- OtherNeurologyOphthalmologyRheumatology
- Modalities
- DeviceHydrogel-based drug delivery therapyBiologic
- Industry
- Implantable Medical Devices
02
Partnerships
TMU - Research Center for Biomedical Devices and Prototyping ProductionDiamond BioFundDomestic and international medical centersRenowned research institutions
Beyond the preview
Go deeper on 3D Global Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 3D Global Biotech.